Trials / Recruiting
RecruitingNCT06175403
A Study of Niacin Regulation
Niacin Regulation of Regional Adipose Tissue Lipolysis
- Status
- Recruiting
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 32 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Adults who gain most of their excess weight in the abdominal area typically do not respond to things that "turn off" fat cells the same way as lean people. The researchers are trying to understand why fat tissue responds differently in people with different body types.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Niacin | Intravenous administration of dose titrated from 10 µg·kg FFM-1·min-1 to 30 µg·kg for approximately 4.5 hours on one occasion |
Timeline
- Start date
- 2024-01-01
- Primary completion
- 2027-05-31
- Completion
- 2027-05-31
- First posted
- 2023-12-18
- Last updated
- 2026-04-13
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06175403. Inclusion in this directory is not an endorsement.